Peptron, Inc.
087010.KQ
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.13T
Close$
$-9571.52
110.7% downside
Current Fair Value
110.7% downsideOvervalued by 110.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.13 Trillion |
|---|---|
| Enterprise Value | $2.15 Trillion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-592.85 |
| Beta | 0.35 |
| Outstanding Shares | 23,243,389 |
Return
| Return on Equity | -15.86% |
|---|---|
| Return on Assets | -12.22% |
| Return on Invested Capital | -20.49% |
Valuation & Multiples
| P/E Ratio | -103.67 |
|---|---|
| PEG | -100.55 |
| Price to Sales | 346.51 |
| Price to Book Ratio | 16.05 |
| Enterprise Value to Revenue | 357.46 |
| Enterprise Value to EBIT | -65.86 |
| Enterprise Value to Net Income | -105 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.24 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Peptron, Inc.
163 employees
CEO: Ho-Il Choi Peptron, Inc. specializes in the creation of peptide-based pharmaceuticals designed to manage chronic health conditions. The company's technological expertise encompasses advanced long-acting drug delivery systems and SmartDepot, an ultr...